GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
iSERA Lifesciences Ltd

iSERA Lifesciences Reports Q2 FY27 Net Loss of INR (13.11) Lakhs

RESULTS ▼ Concern Flagged HIGH RISK
📅 Filed on BSE: 04 Nov 2026, 05:43 PM IST  ·  BSE ID: a9bc0241-3448-41a4-8cbf-5458266ad290
View Original BSE Filing (PDF)
💡
In Simple Terms
The company announced its latest financial results, showing a net loss of INR (13.11) Lakhs for the quarter.
🤖 AI Summary
  • iSERA Lifesciences Limited reported an Un-Audited Standalone Net Loss of INR (13.11) Lakhs for Q2 FY27.
  • Total income for the quarter ended September 30, 2026, was INR 7.88 Lakhs.
  • The company's total expenses for the period reached INR 20.99 Lakhs.
  • Basic Earnings Per Share (EPS) for Q2 FY27 stood at INR (0.62).
  • Unaudited financial results for the half year ended September 30, 2026, were also submitted.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from operations (Q2 FY27)
0.00 INR Lakhs
Not comparable — limited prior period data.
Other Income (Q2 FY27)
7.88 INR Lakhs
Not comparable — limited prior period data.
Total Income (Q2 FY27)
7.88 INR Lakhs
Not comparable — limited prior period data.
Total Expenses (Q2 FY27)
20.99 INR Lakhs
Not comparable — limited prior period data.
Profit/ (Loss) for the period (Q2 FY27)
(13.11) INR Lakhs
Not comparable — limited prior period data.
Basic EPS (Q2 FY27)
(0.62) INR
Not comparable — limited prior period data.
Reserves and Surplus (as of 30 Sep 2026)
(52.92) INR Lakhs
🏢 How This Affects the Company
📈
Business Impact
The company reported minimal revenue from operations, with total income primarily from other sources. This indicates continued limited core business activity.
💰
Financial Impact
The sustained net loss of INR (13.11) Lakhs for Q2 FY27 and INR (33.62) Lakhs for Q1 FY27, as well as (33.62) for the half-year, impacts the company's reserves and potentially cash position. Reserves and Surplus decreased to INR (52.92) Lakhs as of September 30, 2026, from INR (49.81) Lakhs as of March 31, 2026.
⚠️
Risk Impact
The continued operating losses and low total income present a financial risk related to liquidity and ongoing business viability without significant changes or new revenue streams.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are affected by the reported financial performance, specifically the net loss of INR (13.11) Lakhs for Q2 FY27, which impacts the company's retained earnings.
🔍
Management Signal
The approval of these unaudited financial results by the Board of Directors indicates management's adherence to regulatory disclosure requirements for quarterly performance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — check for any revenue from operations.
Future corporate announcements — watch for strategic business updates.
Balance sheet changes — monitor cash and reserves trends.
HIGH RISK Continued net losses, minimal total income and no revenue from operations for the period indicate significant financial risk.
💡 Investor Takeaway
iSERA Lifesciences Limited reported an Un-Audited Standalone Net Loss of INR (13.11) Lakhs for Q2 FY27. Total income for the quarter was INR 7.88 Lakhs, with no revenue from operations. The company's total expenses were INR 20.99 Lakhs, leading to a basic EPS of INR (0.62).
⚖️ Strengths & Concerns

⚠️ Concerns

  • Net loss for Q2 FY27 was INR (13.11) Lakhs, following a net loss of INR (33.62) Lakhs in Q1 FY27.
  • Total income for Q2 FY27 was INR 7.88 Lakhs, composed entirely of other income with no reported revenue from operations.
📅 Company Track Record
iSERA Lifesciences Limited (formerly Covidh Technologies Limited) has previously reported Q2 FY27 net loss of INR (13.11) Lakhs. Earlier filings indicate Board meetings on November 4, 2026, for Q2 FY27 results and August 7, 2026, for Q1 FY27 results, with Q1 FY27 results also showing a net loss.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was iSERA Lifesciences Limited's net profit/loss for Q2 FY27?
iSERA Lifesciences Limited reported an Un-Audited Standalone Net Loss of INR (13.11) Lakhs for the quarter ended September 30, 2026 (Q2 FY27).
What was the total income of iSERA Lifesciences in Q2 FY27?
The total income for iSERA Lifesciences Limited in Q2 FY27 was INR 7.88 Lakhs, derived entirely from other income.
What were the total expenses for iSERA Lifesciences Limited in Q2 FY27?
Total expenses for iSERA Lifesciences Limited for the quarter ended September 30, 2026, amounted to INR 20.99 Lakhs.
What was the Basic Earnings Per Share (EPS) for iSERA Lifesciences in Q2 FY27?
The Basic Earnings Per Share (EPS) for iSERA Lifesciences Limited for Q2 FY27 was INR (0.62).

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.